Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Diabetes
Brought to you by:
MedTech
Dexcom down 40% after CGM sales challenges
President and CEO Kevin Sayer attributed part of the problem to a steep, unanticipated rise in the number of people obtaining G7 rebates.
Conor Hale
Jul 26, 2024 11:30am
Abbott recalls some CGM sensors after inaccurate readings
Jul 25, 2024 2:00pm
Roche nets CE mark for AI-powered CGM in Type 1, Type 2 diabetes
Jul 9, 2024 10:21am
Dexcom’s manufacturing move to lay off 535 in San Diego
Jul 1, 2024 10:35am
Abbott nets pair of FDA over-the-counter CGM clearances
Jun 10, 2024 10:51am
Dexcom goes hands-free, linking G7 directly to the Apple Watch
Jun 5, 2024 10:30am